BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

ABR–Affinity BioReagents to Exhibit in the U.S. Pavilion at Medica, November 14 - 17, 2007


11/9/2007 8:38:42 AM

DENVER and GOLDEN, Colo., Nov. 9 /PRNewswire/ -- ABR-Affinity BioReagents, a leading global antibody manufacturer, announced today that it will once again exhibit at Medica in Dusseldorf, Germany.

Medica is the world's largest medical trade fair, with over 137,000 visitors expected from all parts of the globe. "This is an excellent venue for ABR-Affinity BioReagents. The exposure is global, and it is a wonderful opportunity for us to strengthen relationships with our international business partners and distributors," noted Leslie Martin, Director of Worldwide Marketing. "We have been aggressively expanding our portfolio and now offer over 35,000 products, 16,000 of which are new and just launched in late August. ABR products are available in 43 unique research areas, ranging from Cancer Biology to Heat Shock Proteins, and encompassing Signal Transduction, Vision Research, Neurobiology, Steroids & Hormones, Lipid and Fat Metabolism Regulation, Phosphoproteins, Ion Transport and Muscle Biology. We are proud to be able to contribute to life science research in such a significant manner," Ms. Martin stated.

ABR-Affinity BioReagents is well represented around the world by international distributors with whom ABR has long standing relationships. In business for almost 20 years now, ABR enjoys an excellent reputation among business partners and customers. "We will be looking to fill any existing small gaps in our worldwide distribution network at Medica this year, with an eye toward expanded coverage in Asia and specifically China," noted ABR President Ken Wilczek.

About ABR-Affinity BioReagents

Founded in 1989 with world headquarters in Golden, Colorado, ABR-Affinity BioReagents is a world leader in the manufacture and distribution of monoclonal and polyclonal antibodies, kits, recombinant proteins, siRNA, and custom antibody production services, known as Antibody on Demand(R).

With more than 35,000 antibodies focused in 43 research areas, ABR offers a unique value proposition in the life science industry -- research antibodies that are 100% quality guaranteed or your money back -- with no questions asked.

Utilizing a distribution network encompassing over 55 nations, ABR products are readily available in every research market on the globe. Products are available directly from ABR in the United States, as well as through an exclusive distribution partnership with Fisher Scientific, a division of Thermo Fisher Scientific.

For additional information about ABR-Affinity BioReagents, contact Leslie Martin with ABR media relations at 1-800-527-4535.

CONTACT: Leslie Martin, ABR media relations, 1-800-527-4535

Web site: http://www.bioreagents.com/


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->